echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Alz Res Therapy: a new type of cerebrospinal fluid protein that can effectively distinguish dementia from cognitive decline

    Alz Res Therapy: a new type of cerebrospinal fluid protein that can effectively distinguish dementia from cognitive decline

    • Last Update: 2021-11-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Tau pathology, in the form of neurofibrillary tangles (NFT) of hyperphosphorylated tau, together with amyloid beta (Aβ) plaques, is one of the hallmarks of Alzheimer's disease (AD)


    On the other hand, Aβ42 showed a decrease in CSF level


    immunity

    However, some studies have shown that tau in CSF is very heterogeneous.


    In a recent study, Kaj et al.


    diagnosis





    In the non-AD group, N-224 was found in Parkinson’s disease (PD, p <0.


    The important significance of this study lies in the discovery: N-224 tau can distinguish AD subjects from SCD, and can distinguish between subgroups of non-AD dementia and AD


    N-224 tau can distinguish AD subjects from SCD, and can distinguish subgroups of non-AD dementia and AD





    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.